ScholarIQanswers from OpenAlex
Henry Ford Health System
InstitutionResearch output, impact & collaborations
Henry Ford Health System is a institution indexed in ScholarIQ from OpenAlex.
What is known about Henry Ford Health System?
ScholarIQrecord summary
Henry Ford Health System is a research organisation in Detroit, US. OpenAlex records 19,299 works and 1,641,706 citations for it. 5,291 researchers list it as their most recent affiliation.
How many works does Henry Ford Health System have?
ScholarIQindexed works
Henry Ford Health System has 19,299 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Henry Ford Health System have?
ScholarIQcitation count
Henry Ford Health System has 1,641,706 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Henry Ford Health System?
ScholarIQresearcher count
Henry Ford Health System has 5,291 researchers in the ScholarIQ index.
What is the average h-index at Henry Ford Health System?
ScholarIQavg h-index
Henry Ford Health System has an average h-index of 62.5 in OpenAlex.
What is the ROR of Henry Ford Health System?
ScholarIQror
The ROR for Henry Ford Health System is on the source record.
What is the OpenAlex record for Henry Ford Health System?
ScholarIQopenalex
The OpenAlex for Henry Ford Health System is on the source record.
What is the Wikidata of Henry Ford Health System?
ScholarIQwikidata
The Wikidata for Henry Ford Health System is on the source record.
Who are the most-cited researchers behind Henry Ford Health System?
ScholarIQtop researchers by citations
What are the most-cited papers on Henry Ford Health System?
ScholarIQmost cited works
2013 ACCF/AHA Guideline for the Management of Heart Failure
Clyde W. Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E. Casey, Mark H. Drazner, Gregg C. Fonarow, Stephen A. Geraci, Tamara B. Horwich, James L. Januzzi, Maryl R. Johnson, Edward K. Kasper, Wayne C. Levy, Frederick A. Masoudi, Patrick E. McBride, John J.V. McMurray, Judith E. Mitchell, Pamela N. Peterson, Bárbara Riegel, Flora Sam, Lynne W. Stevenson, W.H. Wilson Tang, Emily J. Tsai, Bruce L. Wilkoff
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
Neil J. Stone, Jennifer G. Robinson, Alice H. Lichtenstein, C. Noel Bairey Merz, Conrad B. Blum, Robert H. Eckel, Anne C. Goldberg, David Gordon, Daniel Levy, Donald M. Lloyd‐Jones, Patrick E. McBride, J. Sanford Schwartz, Susan T. Shero, Sidney C. Smith, Karol E. Watson, Peter W.F. Wilson
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Dómine, Philip R. Clingan, Maximilian J. Hochmair, Steven Powell, Susanna Y. Cheng, Helge Bischoff, Nir Peled, Francesco Grossi, Ross Jennens, Martin Reck, Rina Hui, Edward B. Garon, Michael Boyer, Belén Rubio‐Viqueira, Silvia Novello, Takayasu Kurata, Jhanelle E. Gray, John Vida, Ziwen Wei, Jing Yang, Harry Raftopoulos, M. Catherine Pietanza, Marina Chiara Garassino
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer, Fabrice Barlési, Daniel Waterkamp, Keunchil Park, Fortunato Ciardiello, Joachim von Pawel, Shirish M. Gadgeel, Toyoaki Hida, Dariusz M. Kowalski, Manuel Cobo, Diego Cortinovis, Joseph W. Leach, Jonathan Polikoff, Carlos H. Barrios, Fairooz F. Kabbinavar, Osvaldo Arén Frontera, Filippo de Marinis, Hande Turna, Jong-Seok Lee, Marcus Ballinger, Marcin Kowanetz, Pei He, Daniel S. Chen, Alan Sandler, David R. Gandara
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
Neil J. Stone, Jennifer G. Robinson, Alice H. Lichtenstein, C. Noel Bairey Merz, Conrad B. Blum, Robert H. Eckel, Anne C. Goldberg, David Gordon, Daniel Levy, Donald M. Lloyd‐Jones, Patrick E. McBride, J. Sanford Schwartz, Susan T. Shero, Sidney C. Smith, Karol E. Watson, Peter W.F. Wilson
How much of the research on Henry Ford Health System is open access?
ScholarIQopen access share
83%OPEN ACCESS